Literature DB >> 2253199

Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.

G W Bazill1, T M Dexter.   

Abstract

We investigated the effect of a number of platelet activating factor antagonists on cell killing by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphoryl choline (ET-18-OCH3). Of six platelet activating factor antagonists tested, four were found to protect WEHI-3B leukemic cells against cell death induced by ET-18-OCH3. Certain other compounds, not platelet activating factor antagonists, had similar protective effects. The protective compounds were all lipophilic weak bases. We describe experiments that indicate that these compounds protect by inhibition of endocytic uptake of ET-18-OCH3. Sensitive cells showed rapid endocytic uptake, whereas in resistant cells, uptake was slow. Uptake of ET-18-OCH3 could be suppressed by inhibitors of endocytosis such as chloroquine, monensin, and vinblastine. We conclude that one of the principal determinants of sensitivity or resistance to ether lipids may be the rate at which cells take them up by endocytosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253199

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Cellular uptake and retention measurements of alkylphosphocholines in the SK-BR-3 breast cancer and Molt-4 leukemia cell line using capillary gas chromatography.

Authors:  V Brochez; D Van Heuverswyn; J A Diniz; C R De Potter; E G Van den Eeckhout
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

3.  Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine.

Authors:  Arnold H Van Der Luit; Marianne Budde; Marcel Verheij; Wim J Van Blitterswijk
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

4.  Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.

Authors:  F Javier Pérez-Victoria; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.

Authors:  L L Trulla; A Magistrelli; M Salmona; M T Tacconi
Journal:  Lipids       Date:  1993-05       Impact factor: 1.880

6.  Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment.

Authors:  K Fujiwara; L W Daniel; E J Modest; C A Wallen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process.

Authors:  Cécile Ménez; Marion Buyse; Robert Farinotti; Gillian Barratt
Journal:  Lipids       Date:  2007-02-06       Impact factor: 1.880

8.  Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.

Authors:  F E Bishop; C Dive; S Freeman; A Gescher
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Investigations on the cellular uptake of hexadecylphosphocholine.

Authors:  E A Fleer; D Berkovic; H Eibl; C Unger
Journal:  Lipids       Date:  1993-08       Impact factor: 1.880

Review 10.  Membrane-interactive lipids as experimental anticancer drugs.

Authors:  W E Berdel
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.